Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment

Details for Australian Patent Application No. 2002359288 (hide)

Owner Board of Regents, The University of Texas System Amgen, Inc. The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services, of the United States Government

Inventors Oral, Elif Arioglu; Garg, Abhimanyu; Taylor, Simeon I; Depaoli, Alex M

Agent Spruson & Ferguson

Pub. Number AU-B-2002359288

PCT Number PCT/US02/33875

PCT Pub. Number WO2003/034996

Priority 60/336,394 22.10.01 US

Filing date 22 October 2002

Wipo publication date 6 May 2003

Acceptance publication date 31 July 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

G01N 33/74 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving hormones

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/336,394 22.10.01 US

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002359288

14 July 2005 Amendment Made

  The nature of the amendment is: Add co-applicants Board of Regents, The University of Texas System; The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services, of the United States Government

31 July 2008 Application Accepted

  Published as AU-B-2002359288

27 November 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002359289-NOVEL EPIDERMAL GROWTH FACTOR PROTEIN AND GENE, AND METHODS OF USE THEREFOR

2002359287-ENERGY CONVERSION METHOD AND SYSTEM WITH ENHANCED HEAT ENGINE